chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Investigation, Pain in extremity, Rash, Weight
Clinical narrative: rash was on her back; had pain in her arm; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL1284 and expiry date was not reported), via an unspecified route of administration, on 16Jan2021 (age at vaccination: 70 years), as a single dose for COVID-19 immunization. The patient's medical history included eats eggs like maybe for a couple days she will have a rash on the back. Concomitant medications were not reported. The re-porter said she had the vaccination COVID 19 vaccine on the 16Jan2021 and did nothing and then the next day on 17Jan2021, she had pain in her arm for like 5 minutes and that was it, the second one was a different story. That day she had a rash on her back and she forgot to tell the person she had rash on her back and she took the thing and she went about her day. No further information provided. The next day her arm hurt a little and it hurt on the other arm, in the same place. She did not know if it was sympathetic pain or what but both arms hurt in the muscle towards the back. The rash was on her back rash before the second dose, sometimes when she eats eggs like maybe for a couple days she will have a rash on the back and she had that but it was drying out, she meant to tell the guy and she didn't ask about it, she was rushed it was a rainy day, she had to drive the interstate which was busy and they had to stand under an awning to keep from getting wet, she thought she lost some of her senses and forgot to tell him. She thought the little rash got dark red after the vaccine and she has never had that happen it is usually a little pink thing she does not know if it would be called hives but after the vaccine she got she thinks it was the day after or 2 days after, she didn't recall but the rash intensified it was a dark red color but it was an individual thing there was like 2 that were bigger and very dark red. The patient underwent lab test and procedure included labs work with unknown result on an unspecified date in Feb2021 and weight was 148lbs sometimes it fluctuates to 150lbs on an unspecified date. Outcome of the event had pain in her arm was recovered on 17Jan2021 and for another event, it was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pain, Pyrexia
Clinical narrative: Chills; Fever; Dry heaving; slept from 3pm yesterday until 5am this morning; Body aches; Nausea; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer sponsored program via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration on 01Mar2021 as dose 1, single for COVID-19 immunization. Medical history included COVID-19 in May2020 and laid on bed for 3 weeks. Patient was sick and had no appetite, so she knows she had a mini care of the coronavirus. She also had gastro-intestinal (GI) issues with the virus in May2020. The patient's concomitant medications were not reported. The patient experienced chills, fever, dry heaving and sleep from 15:00 on 02Mar2021 until 05:00 on 03Mar2021 (the next morning). She had a temperature of 99.2 F on 03Mar2021 (reporting day) other than that she feels better. The patient also had body aches and nausea in Mar2021 and people told her that the second vaccine was worse than the first vaccine. The patient wanted to know whether to receive the second dose of vaccination. The outcome of the events chills, fever, dry heaving and sleepiness was recovered on 03Sep2021 at 05:00 while the outcome of body aches and nausea was unknown at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Retching, Somnolence
Clinical narrative: Chills; Fever; Dry heaving; slept from 3pm yesterday until 5am this morning; Body aches; Nausea; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer sponsored program via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration on 01Mar2021 as dose 1, single for COVID-19 immunization. Medical history included COVID-19 in May2020 and laid on bed for 3 weeks. Patient was sick and had no appetite, so she knows she had a mini care of the coronavirus. She also had gastro-intestinal (GI) issues with the virus in May2020. The patient's concomitant medications were not reported. The patient experienced chills, fever, dry heaving and sleep from 15:00 on 02Mar2021 until 05:00 on 03Mar2021 (the next morning). She had a temperature of 99.2 F on 03Mar2021 (reporting day) other than that she feels better. The patient also had body aches and nausea in Mar2021 and people told her that the second vaccine was worse than the first vaccine. The patient wanted to know whether to receive the second dose of vaccination. The outcome of the events chills, fever, dry heaving and sleepiness was recovered on 03Sep2021 at 05:00 while the outcome of body aches and nausea was unknown at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Eyelid ptosis, Rash, Swelling
Clinical narrative: Left eye drooping; Rash and swollen of upper cheek bone; Rash and swollen of upper cheek bones; This is a spontaneous report from a contactable nurse (patient) via other health care professional. A 82-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm in Feb2021 at 13:15 as dose 1, single for COVID-19 immunization. Medical history included heart surgery and allergy to statin and antidepressants. Concomitant medications included apixaban (ELIQUIS); acetylsalicylic acid (ASPIRIN 81) and multivitamins. The patient was not pregnant. The patient was not tested for COVID post vaccination and did not have COVID prior vaccination. In Feb021 at 14:15, the patient experienced rash and swollen of upper cheek bones, left eye drooping. No corrective treatment was received by the patient. The outcome was not recovered for the reported events.  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Decreased appetite, Dizziness, Dyspnoea
Clinical narrative: difficulty breathing; Body aches; Dizziness; Cough; Tight chest; Thirsty; Loss of appetite; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; Lot Number: EN6198 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 11:00 (at the age of 53-years-old) at dose 2, single for COVID-19 immunization. Medical history included kidney disease, diabetes, hypertension, CVA(cerebrovascular accident ), GERD (gastrooesophageal reflux disease), IBS (irritable bowel syndrome), bipolar disorder and others, known allergies to Penicillin. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; Lot Number: EL8982 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 05Feb2021 13:45 (at the age of 53-years-old) at dose 1, single for COVID-19 immunization. The most recent covid-19 vaccine was administered at Doctor's office/urgent care. The patient experienced body aches, dizziness, cough, tight chest, difficulty breathing, some congestion, thirsty and loss of appetite on 27Feb2021 17:00. No treatment was given for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Thirst
Clinical narrative: difficulty breathing; Body aches; Dizziness; Cough; Tight chest; Thirsty; Loss of appetite; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; Lot Number: EN6198 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 27Feb2021 11:00 (at the age of 53-years-old) at dose 2, single for COVID-19 immunization. Medical history included kidney disease, diabetes, hypertension, CVA(cerebrovascular accident ), GERD (gastrooesophageal reflux disease), IBS (irritable bowel syndrome), bipolar disorder and others, known allergies to Penicillin. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; Lot Number: EL8982 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 05Feb2021 13:45 (at the age of 53-years-old) at dose 1, single for COVID-19 immunization. The most recent covid-19 vaccine was administered at Doctor's office/urgent care. The patient experienced body aches, dizziness, cough, tight chest, difficulty breathing, some congestion, thirsty and loss of appetite on 27Feb2021 17:00. No treatment was given for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Fatigue, Headache, Nausea
Clinical narrative: Shortness of breath; fever; nausea; body aches; chills; headache; tired; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 02Ma2021 at 08:00 (at the age of 37-year-old), dose 2, single for COVID-19 immunisation. Medical history included blood clotting disorder. Concomitant medications included apixaban (ELIQUIS) and vitamin B complex (VITAMIN B). The patient previously took cefalexin monohydrate (KEFLEX), levofloxacin (LEVAQUIN), azithromycin and had allergy to these medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. On 02Mar2021 at 23:00, the patient experienced shortness of breath, fever, nausea, body aches, chills, headache, and was tired. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Shortness of breath; fever; nausea; body aches; chills; headache; tired; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 02Ma2021 at 08:00 (at the age of 37-year-old), dose 2, single for COVID-19 immunisation. Medical history included blood clotting disorder. Concomitant medications included apixaban (ELIQUIS) and vitamin B complex (VITAMIN B). The patient previously took cefalexin monohydrate (KEFLEX), levofloxacin (LEVAQUIN), azithromycin and had allergy to these medications. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date, dose 1, single for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive other vaccines four weeks prior. The patient was not pregnant at the time of vaccination. On 02Mar2021 at 23:00, the patient experienced shortness of breath, fever, nausea, body aches, chills, headache, and was tired. No treatment was received for the events. The patient had not been tested for COVID-19 since vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cardiac disorder, Chest pain, Gastrointestinal disorder, Heart rate
Clinical narrative: Extreme chest pain; stomach pain; I have a heart condition; possible problem with my mesentery; I also have had a heart rate of between 90-150; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 27Feb2021 13:15 (Lot number was not reported) (at the age of 23-years-old) as dose 1, single for covid-19 immunisation. Medical history included tachycardia, asthma. The patient received concomitant medications within two weeks of vaccination. The patient did not receive any other vaccine in four weeks of vaccination. The patient previously took penicillin and experienced allergy. The patient did not have covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 28Feb2021 at 16:00, the patient experienced extreme chest pain and stomach pain. She had a heart condition and possible problem with her mesentery. Hence it felt like the vaccine was attacking my weak points. She also had a heart rate of between 90-150. The patient did not receive any treatment for adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Extreme chest pain; stomach pain; I have a heart condition; possible problem with my mesentery; I also have had a heart rate of between 90-150; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 27Feb2021 13:15 (Lot number was not reported) (at the age of 23-years-old) as dose 1, single for covid-19 immunisation. Medical history included tachycardia, asthma. The patient received concomitant medications within two weeks of vaccination. The patient did not receive any other vaccine in four weeks of vaccination. The patient previously took penicillin and experienced allergy. The patient did not have covid-19 prior to vaccination and was not tested for covid-19 post vaccination. On 28Feb2021 at 16:00, the patient experienced extreme chest pain and stomach pain. She had a heart condition and possible problem with her mesentery. Hence it felt like the vaccine was attacking my weak points. She also had a heart rate of between 90-150. The patient did not receive any treatment for adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Nail discolouration, Peripheral coldness, SARS-CoV-2 test
Clinical narrative: cold toes changing color from blue to red in her both feet/blue and cold toes in both feet; cold toes changing color from blue to red in her both feet/Blue and cold toes in both feet; Also her toes are red; This is a spontaneous report from a contactable physician. A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 11Feb2021 as dose 1, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. The patient experienced cold toes changing color from blue to red in her both feet/blue and cold toes in both feet and also her toes are red on 14Feb2021. The patient underwent lab tests and procedures which included PCR and rapid test on an unspecified date and results were negative. Outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Sinusitis
Clinical narrative: headache; cough; sinus drainage; This is a spontaneous report from a contactable other Health care professional via Pfizer sponsored program, reporting herself.  A female patient of unknown age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch no/Lot number: unknown, Expiry date: unknown) via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunization. Medical history included exposure to covid positive (with Negative results). Concomitant medications were not reported. It was reported that she exposed to covid positive but not tested positive however on an unknown date patient was experienced with headache, cough, and sinus drainage and asked if it was ok to get the second dose of the vaccine on the 03Mar2021. On an unknown date, the patient underwent lab tests and procedures which included covid-19 results negative. The outcome the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Hypersensitivity, SARS-CoV-2 antibody test, Swelling
Clinical narrative: Allergic reaction to serum; Swelling; redness; warmth; This is a spontaneous report from a contactable consumer (patient).   A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number was not reported),  via an unspecified route of administration, administered in right arm on 28Feb2021 10:30 (at the age of 70-years-old) as dose 1, single for covid-19 immunization.  Medical history included Breast cancer remission. Patient previously took  Penicillin and experienced allergy.  The patient's concomitant medications were not reported. Prior to vaccination, the patient was not pregnant, not diagnosed with COVID-19, did not receive any other vaccines within 4 weeks and no other medications within 2 weeks. The patient experienced allergic reaction to serum, swelling, redness and warmth on 01Mar2021 11:00.  The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 06Jun2020.  The events were treated with doxycycline antibiotic. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Investigation, Malaise, Penis injury, Testicular injury
Clinical narrative: dick and balls were shrinking, and it's just skin now; dick and balls were shrinking, and it's just skin now; wasn't feeling good right away; he has lost his mojo; This is a spontaneous report from a contactable consumer. This Consumer reported for a 21-year-old male patient who received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date as dose number unknown, single for COVID-19 immunization. The patient's and medical history, concomitant medications and investigation assessment were unknown. On an unknown date it was reported that the patient got the Pfizer Covid vaccine and when he got it he wasn't feeling good right away and his penis and scrotum were shrinking and it was just skin now. Caller stated that he does not have any information to provide, just that he was really healthy. Caller states the patient received the vaccine about 3 days ago and he was in the hospital. States his friend just told him this. Caller does not know when he was hospitalized and they were running tests. He said that the patient was shrinking. No further information was provided. He said that the patient was hurting bad right now. Caller states the patient got the Covid vaccine and has no idea which one and states he has no further information to provide, does not know NDC, lot, or exp. States when he met the patient, he was a healthy happy guy and now he has lost his mojo per his friend. The event outcome was unknown.  PSCC Communication: When verifying information provided with agent caller states it was his friends brother and he lost his penis and it's gone. Caller states can't have this product. He said that it was dangerous   No follow-up attempts were possible; information about lot/batch number could not be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash on my lower back and it got so bad with the itching; Rash on lower back extending down to buttocks within 72 hours of getting the vaccine/Some spots have come up on the trunk on my front; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: LN6202), via an unspecified route of administration, administered in Arm Left on 26Feb2021 12:00 as dose 1, single for covid-19 immunisation. Medical history included bronchiectasis from an unknown date and unknown if ongoing. Concomitant medication included azythromycin and doxyclene taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. On 01Mar2021 19:00, patient experienced rash on lower back extending down to buttocks within 72 hours of getting the vaccine. The rash on her lower back, also some spots have come up on the trunk on my front and it got so bad with the itching on 02Mar2021. The patient went to see a dermatologist and he has prescribed a corticosteroid topical ointment (treatment) for it. The patient wanted to know if she should get the second dose, which is in 3 weeks, and if you are on steroids, should she think about getting the second dose. The outcome of the event was not recovered  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature abnormal
Clinical narrative: if the changes in his temperature are normal or not.; This is a spontaneous report from a contactable consumer (patient, self-reporting). A male patient of an unspecified age received first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 23Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that he got the first dose yesterday, and he was asking if the changes in his temperature are normal or not. The patient underwent lab tests and procedures which included body temperature: changes in his temperature on Feb2021. Outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Fatigue, Myalgia
Clinical narrative: muscle pain; bone pain; tiredness; chills; joint pain; injection site pain; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EN6201 and expiry date not reported), via an unspecified route of administration, administered in Arm Right, on 01Mar2021 16:00 (at the age of 47-year-old), as dose 1, single, for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient had no medical history, no known allergies, and no concomitant medications. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination. Patient was not tested for COVID post vaccination. The patient experienced muscle pain, bone pain, tiredness, chills, joint pain, and injection site pain on 02Mar2021 11:00. Patient received no treatment for the events. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle pain; bone pain; tiredness; chills; joint pain; injection site pain; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EN6201 and expiry date not reported), via an unspecified route of administration, administered in Arm Right, on 01Mar2021 16:00 (at the age of 47-year-old), as dose 1, single, for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient had no medical history, no known allergies, and no concomitant medications. Patient did not receive any other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination. Patient was not tested for COVID post vaccination. The patient experienced muscle pain, bone pain, tiredness, chills, joint pain, and injection site pain on 02Mar2021 11:00. Patient received no treatment for the events. The outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: bad itching, lot of bumps, redness on the arm she received her shot on/ injection site itchy with little red bumps; bad itching, lot of bumps, redness on the arm she received her shot on/ injection site itchy with little red bumps; Swelling/ arm swelling where she got the needle; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm on an unspecified date (Lot number and expiration date was not reported) as dose number unknown, single for COVID-19 immunization.  The patient medical history and concomitant medications were not reported. The patient reported that her arm was and it was a little swollen but that went down and it was still itchy with like little red bumps in the area where she got the needle. The patient did not know what to do for it, and did not know what to put on it, she applied cortisone on it and it seemed to irritate it and itch more. The patient also applied cool compression on it and stated she was warm and irritated. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Circumstance or information capable of leading to medication error, Inflammation, Myalgia, Pain
Clinical narrative: Adds that his wife is wanting to hold back on taking the second dose until the side effects; pain at injection site on the day of injection; joint pain; muscle pain; inflammation; swelling in hands and wrist; pain; This is a spontaneous report from a contactable consumer. A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified (age at vaccination 67 years) date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced adds that his wife is wanting to hold back on taking the second dose until the side effects, on the day of injection pain at injection site on the day of injection, On the second day after the vaccine joint pain, muscle pain, inflammation, swelling in hands and wrist, pain. Reporter stated, her wife had pain seems to subside during day but comes back at night. Also reports that the pain seems to travel throughout her body from one shoulder to the next shoulder. She has consulted her hcp. Patient received treatment of prescribed anti inflammatory which helps the pain. The outcome of event joint pain, muscle pain, inflammation was not recovered, and rest of all outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: Adds that his wife is wanting to hold back on taking the second dose until the side effects; pain at injection site on the day of injection; joint pain; muscle pain; inflammation; swelling in hands and wrist; pain; This is a spontaneous report from a contactable consumer. A 67-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on an unspecified (age at vaccination 67 years) date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced adds that his wife is wanting to hold back on taking the second dose until the side effects, on the day of injection pain at injection site on the day of injection, On the second day after the vaccine joint pain, muscle pain, inflammation, swelling in hands and wrist, pain. Reporter stated, her wife had pain seems to subside during day but comes back at night. Also reports that the pain seems to travel throughout her body from one shoulder to the next shoulder. She has consulted her hcp. Patient received treatment of prescribed anti inflammatory which helps the pain. The outcome of event joint pain, muscle pain, inflammation was not recovered, and rest of all outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: 12-24 hours of severe chills.; This is a spontaneous report from a non-contactable consumer. This male consumer reported for himself.  A male patient with unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On Feb2021, after the vaccination, the patient experienced 12-24 hours of severe chills. The outcome of the events was recovered on Feb2021.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site pain
Clinical narrative: chills; Soreness at the injection site; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional received from Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 19Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, on an unspecified date as dose 1, single for COVID-19 immunization. On 19Feb2021 the patient experienced soreness at the injection site and on 20Feb2021, the patient has chills. Patient wanted to know how long after the second dose she could still experienced reactions. Outcome of the events were unknown.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Gait disturbance, Muscle spasms, Weight bearing difficulty
Clinical narrative: This is a spontaneous report from a contactable consumer from medical information team. A 72-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date not reported) via intramuscular route, in right arm, on 24Feb2021 12:15 (at the age of 72-years-old) at dose 1, 0.3ml single for covid-19 immunization. Medical history included heart (as reported); close to 20 years. The patient had a flu shot on Jan2021 and had no problems with that. There were no concomitant medications. Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient was not administered with any other vaccine on the same date of vaccination. The patient experienced severe/bad muscle spasms, left back pain, pain down her leg into her knee/left knee pain, left hip pain on 25Feb2021. It was also reported that the conditions were progressively getting worse and she can't put weight on that side or walk/move without excruciating pain on Feb2021. The patient had no relevant test results.  Therapeutic measures were taken included Ibuprofen. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary mass, Axillary pain, Headache, Lymphadenopathy
Clinical narrative: headaches; runny nose; back of the throat/sore throat; swollen lymph nodes/Lymph nodes started swelling in the throat and then lymph node under the arm; she washes it hurts and she noticed a lump in the arm pit; noticed a lump in the arm pit; elbow pain and she thought she broke her elbow; bad rash; itching and scratching/It starts on the back of her neck and is by the arm pit in the back/The same thing on the leg; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, within 4 hours after vaccination, patient had a little headache, but not bad. Then she got runny nose, but it did not come out of the front. It went back of the throat. Within 3 or 4 days she got a sore throat.  Her lymph nodes in the throat and under the arm were started swelling. When she washes, it hurts, and noticed a lump in the arm pit. It was okay if she leaves it alone and doesn't bother it. Also reported, she had elbow pain and she thought, she might break her elbow. She had no fever and can get out of the bed. At the time of report, patient had no headache. Then she got a bad rash. She had been itching and scratching. It was reported that she looked like a mangy dog, where rash started on the back of her neck and by the arm pit in the back, also in the trunk where the arm connects to the trunk of the body and found on the leg, below the buttock, where the limbs connect to the body. Patient wanted to know whether she can use cortisone cream  that has been prescribed for her and also could receive 2nd dose in next 2 week. The outcome of the event rash was not recovered, and of headache and swollen lymph nodes was recovered and of all other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pruritus, Rash, Rhinorrhoea
Clinical narrative: headaches; runny nose; back of the throat/sore throat; swollen lymph nodes/Lymph nodes started swelling in the throat and then lymph node under the arm; she washes it hurts and she noticed a lump in the arm pit; noticed a lump in the arm pit; elbow pain and she thought she broke her elbow; bad rash; itching and scratching/It starts on the back of her neck and is by the arm pit in the back/The same thing on the leg; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, within 4 hours after vaccination, patient had a little headache, but not bad. Then she got runny nose, but it did not come out of the front. It went back of the throat. Within 3 or 4 days she got a sore throat.  Her lymph nodes in the throat and under the arm were started swelling. When she washes, it hurts, and noticed a lump in the arm pit. It was okay if she leaves it alone and doesn't bother it. Also reported, she had elbow pain and she thought, she might break her elbow. She had no fever and can get out of the bed. At the time of report, patient had no headache. Then she got a bad rash. She had been itching and scratching. It was reported that she looked like a mangy dog, where rash started on the back of her neck and by the arm pit in the back, also in the trunk where the arm connects to the trunk of the body and found on the leg, below the buttock, where the limbs connect to the body. Patient wanted to know whether she can use cortisone cream  that has been prescribed for her and also could receive 2nd dose in next 2 week. The outcome of the event rash was not recovered, and of headache and swollen lymph nodes was recovered and of all other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain, Swelling, Tenderness
Clinical narrative: flu like symptoms; tiredness; achiness/he just had body aches; swelling; bruising at the injection site; bruising at the injection site /still tender if touched hard and there is still some bruising left; bruising at the injection site /still tender if touched hard and there is still some bruising left; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6201, Expiration Date: 30Jun2021), via an unspecified route of administration in left arm, on 24Feb2021 at 10:45 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization in facility reported as covid relief set up clinic in a community college but not in a military facility. No patient's medical history/other history/family history was reported. There were no concomitant medications/other products reported. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient had no prior vaccinations within 4 weeks of COVID vaccine. The patient felt okay for a couple of days after the vaccination. The patient received the vaccine a week ago and in the last couple of days, the patient noticed of getting flu-like-symptoms on 01Mar2021. The patient didn't had fever or chills, but had achiness and tiredness on 01Mar2021. The patient had pain, swelling, and bruising at the injection site in 2021 that went away after 2-3 days. The patient reported it was still tender if touched hard and there is still some bruising left in 2021. It was reported there was no emergency room (ER) or physician's office visit. The patient wanted to know whether these events were side effects and how long these symptoms are supposed to last. The outcome of pain and swelling was recovered in 2021 while the events flu-like-symptoms and tenderness was not recovered; tiredness and paresthesia was unknown and the event bruising at injection site was recovering at the time of report. It was reported that there was no investigation assessment.   No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site bruising
Clinical narrative: flu like symptoms; tiredness; achiness/he just had body aches; swelling; bruising at the injection site; bruising at the injection site /still tender if touched hard and there is still some bruising left; bruising at the injection site /still tender if touched hard and there is still some bruising left; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6201, Expiration Date: 30Jun2021), via an unspecified route of administration in left arm, on 24Feb2021 at 10:45 (at the age of 66-years-old) as dose 1, single for COVID-19 immunization in facility reported as covid relief set up clinic in a community college but not in a military facility. No patient's medical history/other history/family history was reported. There were no concomitant medications/other products reported. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient had no prior vaccinations within 4 weeks of COVID vaccine. The patient felt okay for a couple of days after the vaccination. The patient received the vaccine a week ago and in the last couple of days, the patient noticed of getting flu-like-symptoms on 01Mar2021. The patient didn't had fever or chills, but had achiness and tiredness on 01Mar2021. The patient had pain, swelling, and bruising at the injection site in 2021 that went away after 2-3 days. The patient reported it was still tender if touched hard and there is still some bruising left in 2021. It was reported there was no emergency room (ER) or physician's office visit. The patient wanted to know whether these events were side effects and how long these symptoms are supposed to last. The outcome of pain and swelling was recovered in 2021 while the events flu-like-symptoms and tenderness was not recovered; tiredness and paresthesia was unknown and the event bruising at injection site was recovering at the time of report. It was reported that there was no investigation assessment.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: injection site pain; muscle pain; chills; fever; This is a spontaneous report from a contactable consumer (patient's husband). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced injection site pain, muscle pain, chills and fever. The outcome was unknown for the reported events. The reporter also asked whether the patient could use the antipyretic.  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement
Clinical narrative: high blood pressure was down; This is a spontaneous report from a contactable other health care professional via Medical information team. A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration on 23Jan2021 at dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. 3 to 4 days after the 1st dose in Jan2021, patient noticed his high blood pressure was down around normal: 120/80. Everything was back to normal. He visited the cardiologist who has no other patient who have taken the vaccine with reports similar to his but advised him to call Pfizer. Caller has also reported to VAERS. He logs his blood pressure daily for his doctor. He was a former surgical technologist and nursing assistant. Currently retired. The outcome of the event was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: patient has a giant bruise on her upper arm and shoulder, and this bruise appeared after her second vaccine dose.  The bruise is getting bigger/spreading.; This is a spontaneous report from a contactable consumer. An elderly non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on an unspecified date (Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not known. It was unknown if the patient had allergies to medications, food, or other products. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination and if the patient has been tested for COVID-19 since the vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on an unspecified date (Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient had a giant bruise on her upper arm and shoulder, and this bruise appeared after her second vaccine dose. The bruise was getting bigger/spreading. It was unknown if the patient received treatment for the events. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.